Endava price target lowered to $42 from $50 at Susquehanna

Susquehanna lowered the firm’s price target on Endava (DAVA) to $42 from $50 and keeps a Positive rating on the shares. The firm said the company is being hit by delays in decision making that impacted both FQ3 and FQ4 guidance. While the pipeline of opportunities appears to be expanding, the CEO shared a very detailed description of deal slippage but Susquehanna remains positive on the shares now that the guidance is more measured.